The GLP is committed to full transparency. Download and review our 2019 Annual Report

Why recent measles outbreaks may represent a ‘new normal’

| | March 28, 2019
measles outbreak
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Back near the start of this century, before the full damage of Andrew Wakefield’s debunked study linking measles vaccine and autism became clear and social networking sites turbo-charged the disruptive power of vaccine opponents, some experts believed the world was ready to rid itself of measles once and for all.

These days, with massive outbreaks in the Philippines and Ukraine, more than 80,000 cases in the past year in Europe, and ongoing epidemics in New York, Washington, Texas, Illinois, and California, measles does not feel like an endangered virus.

There’s less talk about measles eradication in 2019. In fact, projections about the future of measles are much more somber now than they were in the early aughts. More measles, not less, appear to be on the horizon, at least in the near term, experts glumly admit.

Related article:  Pioneering ‘refugee’ from gene therapy's darker days 'kept the faith'

Dr. Nancy Messonnier, director of the CDC’s center for immunization and respiratory diseases, said she believes recent increases in measles cases — after years of very low numbers in the United States — mark a “new normal.”

“In general, nationally, most Americans are vaccinated and it is the pockets of individuals that are unvaccinated,” she said.

Read full, original post: The measles virus was down and out. Now it’s primed for a comeback

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend